is generic tirzepatide fda approved approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Regulatory tracker: FDA starts review

Goldenseal ( Hydrastis canadensis L.) was further confirmed to be protective against AALI by inhibiting CYP2E1 in rats (Yamaura et al., 2011)

Flannick, J

This sharp increase in obesity rates expands the population requiring structured weight-management therapies and clinical support

Szilrd Kiss

Clinical trials supporting Wegovy showed participants lost an average of 15% of body weight over 68 weeks when combined with lifestyle changesa measurable, reproducible outcome

Semaglutide and tirzepatide differ fundamentally in mechanismsemaglutide targets GLP-1 alone, while tirzepatide activates both GLP-1 and GIP pathwaysleading to distinct side effect profiles supported by clinical data